Literature DB >> 29473629

Neurologic diseases in women: Five new things.

Mary Angela O'Neal1.   

Abstract

This review highlights some of the new epidemiologic information concerning sex differences involving combined oral contraceptives and stroke, depression and selective serotonin reuptake inhibitors use during pregnancy, emerging knowledge of the teratogenicity and cognitive effects of anticonvulsants during pregnancy, demyelinating disorders in pregnancy, and the influence of timing of hormonal exposure on the risk of Alzheimer disease.

Entities:  

Year:  2013        PMID： 29473629      PMCID： PMC5798511          DOI： 10.1212/CPJ.0b013e318296f0b9

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


  15 in total

1.  Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study.

Authors:  A-L Ponsonby; R M Lucas; I A van der Mei; K Dear; P C Valery; M P Pender; B V Taylor; T J Kilpatrick; A Coulthard; C Chapman; D Williams; A J McMichael; T Dwyer
Journal:  Neurology       Date:  2012-03-07       Impact factor: 9.910

2.  Neuromyelitis optica and pregnancy.

Authors:  B Bourre; R Marignier; H Zéphir; C Papeix; D Brassat; G Castelnovo; N Collongues; S Vukusic; P Labauge; O Outteryck; B Fontaine; P Vermersch; C Confavreux; J de Seze
Journal:  Neurology       Date:  2012-03-07       Impact factor: 9.910

3.  Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

Authors:  Hanan El Marroun; Vincent W V Jaddoe; James J Hudziak; Sabine J Roza; Eric A P Steegers; Albert Hofman; Frank C Verhulst; Tonya J H White; Bruno H C Stricker; Henning Tiemeier
Journal:  Arch Gen Psychiatry       Date:  2012-07

4.  Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

Authors:  Heli Malm; Miia Artama; Mika Gissler; Annukka Ritvanen
Journal:  Obstet Gynecol       Date:  2011-07       Impact factor: 7.661

Review 5.  Estrogen and the aging brain: an elixir for the weary cortical network.

Authors:  Dani Dumitriu; Peter R Rapp; Bruce S McEwen; John H Morrison
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 6.  The immune system and hormones: review and relevance to pregnancy and contraception in women with MS.

Authors:  V Devonshire; P Duquette; E Dwosh; C Guimond
Journal:  Int MS J       Date:  2003-06

7.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

Review 8.  The neuroprotective effects of estrogen on the aging brain.

Authors:  Ray Norbury; William J Cutter; Jacqueline Compton; Dene M Robertson; Michael Craig; Malcolm Whitehead; Declan G Murphy
Journal:  Exp Gerontol       Date:  2003 Jan-Feb       Impact factor: 4.032

9.  Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

Authors:  Huibo Shao; John C S Breitner; Rachel A Whitmer; Junmin Wang; Kathleen Hayden; Heidi Wengreen; Chris Corcoran; Joann Tschanz; Maria Norton; Ron Munger; Kathleen Welsh-Bohmer; Peter P Zandi
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

10.  Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.

Authors:  Stephen Sidney; T Craig Cheetham; Frederick A Connell; Rita Ouellet-Hellstrom; David J Graham; Daniel Davis; Michael Sorel; Charles P Quesenberry; William O Cooper
Journal:  Contraception       Date:  2012-10-19       Impact factor: 3.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.